» Articles » PMID: 33971314

Suppression of Cancer-associated Bone Loss Through Dynamic Mechanical Loading

Overview
Journal Bone
Date 2021 May 10
PMID 33971314
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Patients afflicted with or being treated for cancer constitute a distinct and alarming subpopulation who exhibit elevated fracture risk and heightened susceptibility to developing secondary osteoporosis. Cancer cells uncouple the regulatory processes central for the adequate regulation of musculoskeletal tissue. Systemically taxing treatments to target tumors or disrupt the molecular elements driving tumor growth place considerable strain on recovery efforts. Skeletal tissue is inherently sensitive to mechanical forces, therefore attention to exercise and mechanical loading as non-pharmacological means to preserve bone during treatment and in post-treatment rehabilitative efforts have been topics of recent focus. This review discusses the dysregulation that cancers and the ensuing metabolic dysfunction that confer adverse effects on musculoskeletal tissues. Additionally, we describe foundational mechanotransduction pathways and the mechanisms by which they influence both musculoskeletal and cancerous cells. Functional and biological implications of mechanical loading at the tissue and cellular levels will be discussed, highlighting the current understanding in the field. Herein, in vitro, translational, and clinical data are summarized to consider the positive impact of exercise and low magnitude mechanical loading on tumor-bearing skeletal tissue.

Citing Articles

Cellulose nanofiber reinforced curcumin-infused calcium phosphate silicate cement for various bone-tissue engineering application.

Lu X, Meng S, Zhou Q, Wu T, Gong X, Wu Q Front Oncol. 2025; 14:1516638.

PMID: 39876894 PMC: 11772290. DOI: 10.3389/fonc.2024.1516638.


Antitumoral-Embedded Biopolymeric Spheres for Implantable Devices.

Grumezescu V, Gherasim O, Galateanu B, Hudita A Pharmaceutics. 2024; 16(6).

PMID: 38931875 PMC: 11207774. DOI: 10.3390/pharmaceutics16060754.


Correlation of CT-based bone mineralization with drilling-force measurements in anatomical specimens is suitable to investigate planning of trans-pedicular spine interventions.

Wolff S, Adler S, Eppler E, Fischer K, Lux A, Rothkotter H Sci Rep. 2024; 14(1):1579.

PMID: 38238459 PMC: 10796759. DOI: 10.1038/s41598-023-50204-2.


Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells.

Cui C, Huo Q, Xiong X, Li K, Fishel M, Li B Pharmaceutics. 2023; 15(10).

PMID: 37896207 PMC: 10610494. DOI: 10.3390/pharmaceutics15102447.


Cancer-on-chip: a 3D model for the study of the tumor microenvironment.

Cauli E, Polidoro M, Marzorati S, Bernardi C, Rasponi M, Lleo A J Biol Eng. 2023; 17(1):53.

PMID: 37592292 PMC: 10436436. DOI: 10.1186/s13036-023-00372-6.


References
1.
Gilchrist S, Howard V, Akinyemiju T, Judd S, Cushman M, Hooker S . Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults. JAMA Oncol. 2020; 6(8):1210-1217. PMC: 7303924. DOI: 10.1001/jamaoncol.2020.2045. View

2.
Lynch C . Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis. Bone. 2010; 48(1):44-53. DOI: 10.1016/j.bone.2010.06.007. View

3.
Saad F, Lipton A, Cook R, Chen Y, Smith M, Coleman R . Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007; 110(8):1860-7. DOI: 10.1002/cncr.22991. View

4.
Case N, Ma M, Sen B, Xie Z, Gross T, Rubin J . Beta-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem. 2008; 283(43):29196-205. PMC: 2570859. DOI: 10.1074/jbc.M801907200. View

5.
Campbell K, Winters-Stone K, Wiskemann J, May A, Schwartz A, Courneya K . Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019; 51(11):2375-2390. PMC: 8576825. DOI: 10.1249/MSS.0000000000002116. View